[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Nerve Biologic Products, Market Insights and Forecast to 2026

September 2020 | 114 pages | ID: C4CEF6E82872EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Nerve Biologic Products market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nerve Biologic Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Nerve Biologic Products market is segmented into
  • Nerve Conduit
  • Nerve Wrap
  • Nerve Graft
  • Others
Segment by Application, the Nerve Biologic Products market is segmented into
  • Direct Nerve Repair/Neurorrhaphy
  • Nerve Grafting
Regional and Country-level Analysis
The Nerve Biologic Products market is analysed and market size information is provided by regions (countries).

The key regions covered in the Nerve Biologic Products market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Nerve Biologic Products Market Share Analysis
Nerve Biologic Products market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nerve Biologic Products business, the date to enter into the Nerve Biologic Products market, Nerve Biologic Products product introduction, recent developments, etc.

The major vendors covered:
  • Axogen
  • Integra
  • Synovis
  • Collagen Matrix
  • Polyganics
  • Checkpoint Surgical
  • Neurotex
1 STUDY COVERAGE

1.1 Nerve Biologic Products Product Introduction
1.2 Market Segments
1.3 Key Nerve Biologic Products Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
  1.4.1 Global Nerve Biologic Products Market Size Growth Rate by Type
  1.4.2 Nerve Conduit
  1.4.3 Nerve Wrap
  1.4.4 Nerve Graft
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Nerve Biologic Products Market Size Growth Rate by Application
  1.5.2 Direct Nerve Repair/Neurorrhaphy
  1.5.3 Nerve Grafting
1.6 Coronavirus Disease 2019 (Covid-19): Nerve Biologic Products Industry Impact
  1.6.1 How the Covid-19 is Affecting the Nerve Biologic Products Industry
    1.6.1.1 Nerve Biologic Products Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Nerve Biologic Products Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Nerve Biologic Products Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Nerve Biologic Products Market Size Estimates and Forecasts
  2.1.1 Global Nerve Biologic Products Revenue 2015-2026
  2.1.2 Global Nerve Biologic Products Sales 2015-2026
2.2 Nerve Biologic Products Market Size by Region: 2020 Versus 2026
  2.2.1 Global Nerve Biologic Products Retrospective Market Scenario in Sales by Region: 2015-2020
  2.2.2 Global Nerve Biologic Products Retrospective Market Scenario in Revenue by Region: 2015-2020

3 GLOBAL NERVE BIOLOGIC PRODUCTS COMPETITOR LANDSCAPE BY PLAYERS

3.1 Nerve Biologic Products Sales by Manufacturers
  3.1.1 Nerve Biologic Products Sales by Manufacturers (2015-2020)
  3.1.2 Nerve Biologic Products Sales Market Share by Manufacturers (2015-2020)
3.2 Nerve Biologic Products Revenue by Manufacturers
  3.2.1 Nerve Biologic Products Revenue by Manufacturers (2015-2020)
  3.2.2 Nerve Biologic Products Revenue Share by Manufacturers (2015-2020)
  3.2.3 Global Nerve Biologic Products Market Concentration Ratio (CR5 and HHI) (2015-2020)
  3.2.4 Global Top 10 and Top 5 Companies by Nerve Biologic Products Revenue in 2019
  3.2.5 Global Nerve Biologic Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Nerve Biologic Products Price by Manufacturers
3.4 Nerve Biologic Products Manufacturing Base Distribution, Product Types
  3.4.1 Nerve Biologic Products Manufacturers Manufacturing Base Distribution, Headquarters
  3.4.2 Manufacturers Nerve Biologic Products Product Type
  3.4.3 Date of International Manufacturers Enter into Nerve Biologic Products Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Nerve Biologic Products Market Size by Type (2015-2020)
  4.1.1 Global Nerve Biologic Products Sales by Type (2015-2020)
  4.1.2 Global Nerve Biologic Products Revenue by Type (2015-2020)
  4.1.3 Nerve Biologic Products Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nerve Biologic Products Market Size Forecast by Type (2021-2026)
  4.2.1 Global Nerve Biologic Products Sales Forecast by Type (2021-2026)
  4.2.2 Global Nerve Biologic Products Revenue Forecast by Type (2021-2026)
  4.2.3 Nerve Biologic Products Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nerve Biologic Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Nerve Biologic Products Market Size by Application (2015-2020)
  5.1.1 Global Nerve Biologic Products Sales by Application (2015-2020)
  5.1.2 Global Nerve Biologic Products Revenue by Application (2015-2020)
  5.1.3 Nerve Biologic Products Price by Application (2015-2020)
5.2 Nerve Biologic Products Market Size Forecast by Application (2021-2026)
  5.2.1 Global Nerve Biologic Products Sales Forecast by Application (2021-2026)
  5.2.2 Global Nerve Biologic Products Revenue Forecast by Application (2021-2026)
  5.2.3 Global Nerve Biologic Products Price Forecast by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Nerve Biologic Products by Country
  6.1.1 North America Nerve Biologic Products Sales by Country
  6.1.2 North America Nerve Biologic Products Revenue by Country
  6.1.3 U.S.
  6.1.4 Canada
6.2 North America Nerve Biologic Products Market Facts & Figures by Type
6.3 North America Nerve Biologic Products Market Facts & Figures by Application

7 EUROPE

7.1 Europe Nerve Biologic Products by Country
  7.1.1 Europe Nerve Biologic Products Sales by Country
  7.1.2 Europe Nerve Biologic Products Revenue by Country
  7.1.3 Germany
  7.1.4 France
  7.1.5 U.K.
  7.1.6 Italy
  7.1.7 Russia
7.2 Europe Nerve Biologic Products Market Facts & Figures by Type
7.3 Europe Nerve Biologic Products Market Facts & Figures by Application

8 ASIA PACIFIC

8.1 Asia Pacific Nerve Biologic Products by Region
  8.1.1 Asia Pacific Nerve Biologic Products Sales by Region
  8.1.2 Asia Pacific Nerve Biologic Products Revenue by Region
  8.1.3 China
  8.1.4 Japan
  8.1.5 South Korea
  8.1.6 India
  8.1.7 Australia
  8.1.8 Taiwan
  8.1.9 Indonesia
  8.1.10 Thailand
  8.1.11 Malaysia
  8.1.12 Philippines
  8.1.13 Vietnam
8.2 Asia Pacific Nerve Biologic Products Market Facts & Figures by Type
8.3 Asia Pacific Nerve Biologic Products Market Facts & Figures by Application

9 LATIN AMERICA

9.1 Latin America Nerve Biologic Products by Country
  9.1.1 Latin America Nerve Biologic Products Sales by Country
  9.1.2 Latin America Nerve Biologic Products Revenue by Country
  9.1.3 Mexico
  9.1.4 Brazil
  9.1.5 Argentina
9.2 Central & South America Nerve Biologic Products Market Facts & Figures by Type
9.3 Central & South America Nerve Biologic Products Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

10.1 Middle East and Africa Nerve Biologic Products by Country
  10.1.1 Middle East and Africa Nerve Biologic Products Sales by Country
  10.1.2 Middle East and Africa Nerve Biologic Products Revenue by Country
  10.1.3 Turkey
  10.1.4 Saudi Arabia
  10.1.5 U.A.E
10.2 Middle East and Africa Nerve Biologic Products Market Facts & Figures by Type
10.3 Middle East and Africa Nerve Biologic Products Market Facts & Figures by Application

11 COMPANY PROFILES

11.1 Axogen
  11.1.1 Axogen Corporation Information
  11.1.2 Axogen Description, Business Overview and Total Revenue
  11.1.3 Axogen Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Axogen Nerve Biologic Products Products Offered
  11.1.5 Axogen Recent Development
11.2 Integra
  11.2.1 Integra Corporation Information
  11.2.2 Integra Description, Business Overview and Total Revenue
  11.2.3 Integra Sales, Revenue and Gross Margin (2015-2020)
  11.2.4 Integra Nerve Biologic Products Products Offered
  11.2.5 Integra Recent Development
11.3 Synovis
  11.3.1 Synovis Corporation Information
  11.3.2 Synovis Description, Business Overview and Total Revenue
  11.3.3 Synovis Sales, Revenue and Gross Margin (2015-2020)
  11.3.4 Synovis Nerve Biologic Products Products Offered
  11.3.5 Synovis Recent Development
11.4 Collagen Matrix
  11.4.1 Collagen Matrix Corporation Information
  11.4.2 Collagen Matrix Description, Business Overview and Total Revenue
  11.4.3 Collagen Matrix Sales, Revenue and Gross Margin (2015-2020)
  11.4.4 Collagen Matrix Nerve Biologic Products Products Offered
  11.4.5 Collagen Matrix Recent Development
11.5 Polyganics
  11.5.1 Polyganics Corporation Information
  11.5.2 Polyganics Description, Business Overview and Total Revenue
  11.5.3 Polyganics Sales, Revenue and Gross Margin (2015-2020)
  11.5.4 Polyganics Nerve Biologic Products Products Offered
  11.5.5 Polyganics Recent Development
11.6 Checkpoint Surgical
  11.6.1 Checkpoint Surgical Corporation Information
  11.6.2 Checkpoint Surgical Description, Business Overview and Total Revenue
  11.6.3 Checkpoint Surgical Sales, Revenue and Gross Margin (2015-2020)
  11.6.4 Checkpoint Surgical Nerve Biologic Products Products Offered
  11.6.5 Checkpoint Surgical Recent Development
11.7 Neurotex
  11.7.1 Neurotex Corporation Information
  11.7.2 Neurotex Description, Business Overview and Total Revenue
  11.7.3 Neurotex Sales, Revenue and Gross Margin (2015-2020)
  11.7.4 Neurotex Nerve Biologic Products Products Offered
  11.7.5 Neurotex Recent Development
11.1 Axogen
  11.1.1 Axogen Corporation Information
  11.1.2 Axogen Description, Business Overview and Total Revenue
  11.1.3 Axogen Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Axogen Nerve Biologic Products Products Offered
  11.1.5 Axogen Recent Development

12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)

12.1 Nerve Biologic Products Market Estimates and Projections by Region
  12.1.1 Global Nerve Biologic Products Sales Forecast by Regions 2021-2026
  12.1.2 Global Nerve Biologic Products Revenue Forecast by Regions 2021-2026
12.2 North America Nerve Biologic Products Market Size Forecast (2021-2026)
  12.2.1 North America: Nerve Biologic Products Sales Forecast (2021-2026)
  12.2.2 North America: Nerve Biologic Products Revenue Forecast (2021-2026)
  12.2.3 North America: Nerve Biologic Products Market Size Forecast by Country (2021-2026)
12.3 Europe Nerve Biologic Products Market Size Forecast (2021-2026)
  12.3.1 Europe: Nerve Biologic Products Sales Forecast (2021-2026)
  12.3.2 Europe: Nerve Biologic Products Revenue Forecast (2021-2026)
  12.3.3 Europe: Nerve Biologic Products Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Nerve Biologic Products Market Size Forecast (2021-2026)
  12.4.1 Asia Pacific: Nerve Biologic Products Sales Forecast (2021-2026)
  12.4.2 Asia Pacific: Nerve Biologic Products Revenue Forecast (2021-2026)
  12.4.3 Asia Pacific: Nerve Biologic Products Market Size Forecast by Region (2021-2026)
12.5 Latin America Nerve Biologic Products Market Size Forecast (2021-2026)
  12.5.1 Latin America: Nerve Biologic Products Sales Forecast (2021-2026)
  12.5.2 Latin America: Nerve Biologic Products Revenue Forecast (2021-2026)
  12.5.3 Latin America: Nerve Biologic Products Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Nerve Biologic Products Market Size Forecast (2021-2026)
  12.6.1 Middle East and Africa: Nerve Biologic Products Sales Forecast (2021-2026)
  12.6.2 Middle East and Africa: Nerve Biologic Products Revenue Forecast (2021-2026)
  12.6.3 Middle East and Africa: Nerve Biologic Products Market Size Forecast by Country (2021-2026)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nerve Biologic Products Players (Opinion Leaders)

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

14.1 Value Chain Analysis
14.2 Nerve Biologic Products Customers
14.3 Sales Channels Analysis
  14.3.1 Sales Channels
  14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details
LIST OF TABLES

Table 1. Nerve Biologic Products Market Segments
Table 2. Ranking of Global Top Nerve Biologic Products Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nerve Biologic Products Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Nerve Conduit
Table 5. Major Manufacturers of Nerve Wrap
Table 6. Major Manufacturers of Nerve Graft
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Nerve Biologic Products Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Nerve Biologic Products Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Nerve Biologic Products Players to Combat Covid-19 Impact
Table 13. Global Nerve Biologic Products Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Nerve Biologic Products Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Nerve Biologic Products Sales by Regions 2015-2020 (K Units)
Table 16. Global Nerve Biologic Products Sales Market Share by Regions (2015-2020)
Table 17. Global Nerve Biologic Products Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Nerve Biologic Products Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Nerve Biologic Products Sales Share by Manufacturers (2015-2020)
Table 20. Global Nerve Biologic Products Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Nerve Biologic Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nerve Biologic Products as of 2019)
Table 22. Nerve Biologic Products Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Nerve Biologic Products Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Nerve Biologic Products Price (2015-2020) (USD/Unit)
Table 25. Nerve Biologic Products Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Nerve Biologic Products Product Type
Table 27. Date of International Manufacturers Enter into Nerve Biologic Products Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Nerve Biologic Products Sales by Type (2015-2020) (K Units)
Table 30. Global Nerve Biologic Products Sales Share by Type (2015-2020)
Table 31. Global Nerve Biologic Products Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Nerve Biologic Products Revenue Share by Type (2015-2020)
Table 33. Nerve Biologic Products Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Nerve Biologic Products Sales by Application (2015-2020) (K Units)
Table 35. Global Nerve Biologic Products Sales Share by Application (2015-2020)
Table 36. North America Nerve Biologic Products Sales by Country (2015-2020) (K Units)
Table 37. North America Nerve Biologic Products Sales Market Share by Country (2015-2020)
Table 38. North America Nerve Biologic Products Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Nerve Biologic Products Revenue Market Share by Country (2015-2020)
Table 40. North America Nerve Biologic Products Sales by Type (2015-2020) (K Units)
Table 41. North America Nerve Biologic Products Sales Market Share by Type (2015-2020)
Table 42. North America Nerve Biologic Products Sales by Application (2015-2020) (K Units)
Table 43. North America Nerve Biologic Products Sales Market Share by Application (2015-2020)
Table 44. Europe Nerve Biologic Products Sales by Country (2015-2020) (K Units)
Table 45. Europe Nerve Biologic Products Sales Market Share by Country (2015-2020)
Table 46. Europe Nerve Biologic Products Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Nerve Biologic Products Revenue Market Share by Country (2015-2020)
Table 48. Europe Nerve Biologic Products Sales by Type (2015-2020) (K Units)
Table 49. Europe Nerve Biologic Products Sales Market Share by Type (2015-2020)
Table 50. Europe Nerve Biologic Products Sales by Application (2015-2020) (K Units)
Table 51. Europe Nerve Biologic Products Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Nerve Biologic Products Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Nerve Biologic Products Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Nerve Biologic Products Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Nerve Biologic Products Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Nerve Biologic Products Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Nerve Biologic Products Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Nerve Biologic Products Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Nerve Biologic Products Sales Market Share by Application (2015-2020)
Table 60. Latin America Nerve Biologic Products Sales by Country (2015-2020) (K Units)
Table 61. Latin America Nerve Biologic Products Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Nerve Biologic Products Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Nerve Biologic Products Revenue Market Share by Country (2015-2020)
Table 64. Latin America Nerve Biologic Products Sales by Type (2015-2020) (K Units)
Table 65. Latin America Nerve Biologic Products Sales Market Share by Type (2015-2020)
Table 66. Latin America Nerve Biologic Products Sales by Application (2015-2020) (K Units)
Table 67. Latin America Nerve Biologic Products Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Nerve Biologic Products Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Nerve Biologic Products Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Nerve Biologic Products Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Nerve Biologic Products Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Nerve Biologic Products Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Nerve Biologic Products Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Nerve Biologic Products Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Nerve Biologic Products Sales Market Share by Application (2015-2020)
Table 76. Axogen Corporation Information
Table 77. Axogen Description and Major Businesses
Table 78. Axogen Nerve Biologic Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Axogen Product
Table 80. Axogen Recent Development
Table 81. Integra Corporation Information
Table 82. Integra Description and Major Businesses
Table 83. Integra Nerve Biologic Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Integra Product
Table 85. Integra Recent Development
Table 86. Synovis Corporation Information
Table 87. Synovis Description and Major Businesses
Table 88. Synovis Nerve Biologic Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Synovis Product
Table 90. Synovis Recent Development
Table 91. Collagen Matrix Corporation Information
Table 92. Collagen Matrix Description and Major Businesses
Table 93. Collagen Matrix Nerve Biologic Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Collagen Matrix Product
Table 95. Collagen Matrix Recent Development
Table 96. Polyganics Corporation Information
Table 97. Polyganics Description and Major Businesses
Table 98. Polyganics Nerve Biologic Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Polyganics Product
Table 100. Polyganics Recent Development
Table 101. Checkpoint Surgical Corporation Information
Table 102. Checkpoint Surgical Description and Major Businesses
Table 103. Checkpoint Surgical Nerve Biologic Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Checkpoint Surgical Product
Table 105. Checkpoint Surgical Recent Development
Table 106. Neurotex Corporation Information
Table 107. Neurotex Description and Major Businesses
Table 108. Neurotex Nerve Biologic Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Neurotex Product
Table 110. Neurotex Recent Development
Table 111. Global Nerve Biologic Products Sales Forecast by Regions (2021-2026) (K Units)
Table 112. Global Nerve Biologic Products Sales Market Share Forecast by Regions (2021-2026)
Table 113. Global Nerve Biologic Products Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 114. Global Nerve Biologic Products Revenue Market Share Forecast by Regions (2021-2026)
Table 115. North America: Nerve Biologic Products Sales Forecast by Country (2021-2026) (K Units)
Table 116. North America: Nerve Biologic Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Europe: Nerve Biologic Products Sales Forecast by Country (2021-2026) (K Units)
Table 118. Europe: Nerve Biologic Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Asia Pacific: Nerve Biologic Products Sales Forecast by Region (2021-2026) (K Units)
Table 120. Asia Pacific: Nerve Biologic Products Revenue Forecast by Region (2021-2026) (US$ Million)
Table 121. Latin America: Nerve Biologic Products Sales Forecast by Country (2021-2026) (K Units)
Table 122. Latin America: Nerve Biologic Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Middle East and Africa: Nerve Biologic Products Sales Forecast by Country (2021-2026) (K Units)
Table 124. Middle East and Africa: Nerve Biologic Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key Nerve Biologic Products Players
Table 129. Nerve Biologic Products Customers List
Table 130. Nerve Biologic Products Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Nerve Biologic Products Product Picture
Figure 2. Global Nerve Biologic Products Sales Market Share by Type in 2020 & 2026
Figure 3. Nerve Conduit Product Picture
Figure 4. Nerve Wrap Product Picture
Figure 5. Nerve Graft Product Picture
Figure 6. Others Product Picture
Figure 7. Global Nerve Biologic Products Sales Market Share by Application in 2020 & 2026
Figure 8. Direct Nerve Repair/Neurorrhaphy
Figure 9. Nerve Grafting
Figure 10. Nerve Biologic Products Report Years Considered
Figure 11. Global Nerve Biologic Products Market Size 2015-2026 (US$ Million)
Figure 12. Global Nerve Biologic Products Sales 2015-2026 (K Units)
Figure 13. Global Nerve Biologic Products Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Nerve Biologic Products Sales Market Share by Region (2015-2020)
Figure 15. Global Nerve Biologic Products Sales Market Share by Region in 2019
Figure 16. Global Nerve Biologic Products Revenue Market Share by Region (2015-2020)
Figure 17. Global Nerve Biologic Products Revenue Market Share by Region in 2019
Figure 18. Global Nerve Biologic Products Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Nerve Biologic Products Revenue in 2019
Figure 20. Nerve Biologic Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Nerve Biologic Products Sales Market Share by Type (2015-2020)
Figure 22. Global Nerve Biologic Products Sales Market Share by Type in 2019
Figure 23. Global Nerve Biologic Products Revenue Market Share by Type (2015-2020)
Figure 24. Global Nerve Biologic Products Revenue Market Share by Type in 2019
Figure 25. Global Nerve Biologic Products Market Share by Price Range (2015-2020)
Figure 26. Global Nerve Biologic Products Sales Market Share by Application (2015-2020)
Figure 27. Global Nerve Biologic Products Sales Market Share by Application in 2019
Figure 28. Global Nerve Biologic Products Revenue Market Share by Application (2015-2020)
Figure 29. Global Nerve Biologic Products Revenue Market Share by Application in 2019
Figure 30. North America Nerve Biologic Products Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Nerve Biologic Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Nerve Biologic Products Sales Market Share by Country in 2019
Figure 33. North America Nerve Biologic Products Revenue Market Share by Country in 2019
Figure 34. U.S. Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Nerve Biologic Products Market Share by Type in 2019
Figure 39. North America Nerve Biologic Products Market Share by Application in 2019
Figure 40. Europe Nerve Biologic Products Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Nerve Biologic Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Nerve Biologic Products Sales Market Share by Country in 2019
Figure 43. Europe Nerve Biologic Products Revenue Market Share by Country in 2019
Figure 44. Germany Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Nerve Biologic Products Market Share by Type in 2019
Figure 55. Europe Nerve Biologic Products Market Share by Application in 2019
Figure 56. Asia Pacific Nerve Biologic Products Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Nerve Biologic Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Nerve Biologic Products Sales Market Share by Region in 2019
Figure 59. Asia Pacific Nerve Biologic Products Revenue Market Share by Region in 2019
Figure 60. China Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Nerve Biologic Products Market Share by Type in 2019
Figure 83. Asia Pacific Nerve Biologic Products Market Share by Application in 2019
Figure 84. Latin America Nerve Biologic Products Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Nerve Biologic Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Nerve Biologic Products Sales Market Share by Country in 2019
Figure 87. Latin America Nerve Biologic Products Revenue Market Share by Country in 2019
Figure 88. Mexico Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Nerve Biologic Products Market Share by Type in 2019
Figure 95. Latin America Nerve Biologic Products Market Share by Application in 2019
Figure 96. Middle East and Africa Nerve Biologic Products Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Nerve Biologic Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Nerve Biologic Products Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Nerve Biologic Products Revenue Market Share by Country in 2019
Figure 100. Turkey Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Nerve Biologic Products Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Nerve Biologic Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Nerve Biologic Products Market Share by Type in 2019
Figure 107. Middle East and Africa Nerve Biologic Products Market Share by Application in 2019
Figure 108. Axogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Integra Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Synovis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Collagen Matrix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Polyganics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Checkpoint Surgical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Neurotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Nerve Biologic Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. North America Nerve Biologic Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Nerve Biologic Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Europe Nerve Biologic Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Nerve Biologic Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Asia Pacific Nerve Biologic Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Nerve Biologic Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Latin America Nerve Biologic Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Nerve Biologic Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Middle East and Africa Nerve Biologic Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed


More Publications